Meta-analysis of metabolic syndrome and benign prostatic hyperplasia in Chinese patients

详细信息    查看全文

• 作者：Chen Zou ; Dandan Gong ; Na Fang ; Yu Fan
• 关键词：Metabolic syndrome ; Benign prostatic hyperplasia ; Meta ; analysis
• 刊名：World Journal of Urology
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：34
• 期：2
• 页码：281-289
• 全文大小：1,603 KB
• 参考文献：1.Issa MM, Regan TS (2007) Medical therapy for benign prostatic hyperplasia—present and future impact. Am J Manag Care 13(Suppl 1):S4–S9PubMed
  2.Barry MJ, Fowler Jr FJ, Bin L et al (1997) The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol 157(1):10–14; discussion 14–15
  3.Stroup SP, Palazzi-Churas K, Kopp RP et al (2012) Trends in adverse events of benign prostatic hyperplasia (BPH) in the USA, 1998 to 2008. BJU Int 109(1):84–87CrossRef PubMed
  4.Parsons JK (2007) Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol 178(2):395–401CrossRef PubMed
  5.De Nunzio C, Aronson W, Freedland SJ et al (2012) The correlation between metabolic syndrome and prostatic diseases. Eur Urol 61(3):560–570CrossRef PubMed
  6.Hammarsten J, Hogstedt B, Holthuis N et al (1998) Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1(3):157–162CrossRef PubMed
  7.Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735–2752CrossRef PubMed
  8.Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23(5):469–480CrossRef PubMed
  9.Cooperative Research Group of Diabetic metabolic syndrome of Chinese Medical Association (2004) Proposal of endocrine branch of Chinese medical association. Chin J Diabetes 12(3):156–161
  10.Joint committee for developing Chinese guidelines on prevention and treatment of dyslipidemia in adults (2007) Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chin J Cardiol 35(5):390–416
  11.Wells G, Shea B, O’Connell D et al (2014) The Newcastle–Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http://​www.​ohri.​ca/​programs/​clinical_​epidemiology/​oxford.​asp . Accessed 20 Dec 2014
  12.Higgins JPT, Green Se Cochrane handbook for systematic reviews of interventions version 5.0.2. www.​cochrane-handbook.​org
  13.Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634PubMedCentral CrossRef PubMed
  14.Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101CrossRef PubMed
  15.Cao B, Sun HB, Su JH et al (2010) Correlation between metabolic syndrome and clinical progression in patients with benign prostatic hyperplasia. Zhonghua Yi Xue Za Zhi 90(40):2823–2825PubMed
  16.Chen DX, Chen QQ, Li YB (2010) Clinical characteristics of patients with prostatic hyperplasia combined metabolic syndrome. Chin J Gerontol 30(14):2065–2066
  17.Zhou Y, Zhou SB, Wang W et al (2012) Clinical correlation of benign prostatic hyperplasia and metabolic syndrome in elderly patients. Chin J Gerontol 32(11):4895–4898
  18.Wei CY, Zhang DD, Lu T (2012) Relationship between benign prostatic hyperplasia and metabolic syndrome in elderly men. J Dalian Med Univ 34(1):75–77
  19.Liu C, Du WH, Zheng TL et al (2012) Relationship between metabolic syndrome and benign prostatic hyperplasia. Prog Mod Biomedici II 29(12):5695–5697
  20.Ding LH (2012) Relationship between metabolic syndrome and prostate volume in BPH under 50 years old. Chin J Endourol (Electron Ed) 6(4):296–300
  21.Wang J, Yang B, Feng YL et al (2012) Relationship between metabolic syndrome and senile prostate hyperplasia. Chin J Diffic Compl Cas 11(10):791–792
  22.Miao L, Chen Z, Gao CY et al (2013) Influence of metabolic syndrome on aged patients with benign prostatic hyperplasia. J Mod Med Health 29(10):1446–1450
  23.Zhang YW, Yang J (2013) The effect of metabolic syndrome on pathogenesis of benign prostatic hyperplasia. China Mod Dr 51(9):8–10
  24.Zhou XP, Xiong GG, Xu HP et al (2013) Correlation analysis of metabolic syndrome and benign prostatic hyperplasia. China Foreign Med Treat 32(27):54–55
  25.Wang JF, Gai YN, Sun YH (2013) Clinical study of correlation between BPH and metabolic syndrome in elderly. J Clin Urol (China) 28(12):932–934
  26.Bao JC, Wang HQ, Zuo JQ et al (2013) Study on the relationship metabolic syndrome and prostate volume of annual growth rate. Med Inf 26(1):242–243
  27.Yu CH, Liu ZZ, Su YQ et al (2013) Correlation of metabolic syndrome and prostatic hyperplasia. Tianjin Med J 41(11):1117–1118
  28.Wang MH, Mo LY, Wu YH (2014) Clinical correlation of benign prostatic hyperplasia and metabolic syndrome in elderly patients. J Clin Med Pract 18(17):149–151
  29.Pan JG, Jiang C, Luo R et al (2014) Association of metabolic syndrome and benign prostatic hyperplasia in Chinese patients of different age decades. Urol Int 93(1):10–16PubMed
  30.Zhang X, Zeng X, Liu Y et al (2014) Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men. Urol Int 93(2):214–219CrossRef PubMed
  31.Mochtar CA, Kiemeney LA, van Riemsdijk MM et al (2003) Prostate-specific antigen as an estimator of prostate volume in the management of patients with symptomatic benign prostatic hyperplasia. Eur Urol 44(6):695–700CrossRef PubMed
  32.Crawford ED, Wilson SS, McConnell JD et al (2006) Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo. J Urol 175(4): 1422–1426; discussion 1426–1427
  33.Baillargeon J, Pollock BH, Kristal AR et al (2005) The association of body mass index and prostate-specific antigen in a population-based study. Cancer 103(5):1092–1095CrossRef PubMed
  34.Ozden C, Ozdal OL, Urgancioglu G, Koyuncu H et al (2007) The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur Urol 51(1): 199–203; discussion 204–196
  35.Jeong JH, Kim ET, Kim DK (2011) Association of metabolic syndrome and benign prostate enlargement in young korean males. Korean J Urol 52(11):757–762PubMedCentral CrossRef PubMed
  36.Lee YC, Liu CC, Juan YS et al (2013) The impact of metabolic syndrome on the responsiveness to alpha1-blocker in men with BPH/LUTS. Int J Clin Pract 67(4):356–362CrossRef PubMed
  37.Gao Y, Wang M, Zhang H et al (2012) Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey. Urology 79(1):194–201CrossRef PubMed
  38.Park YW, Min SK, Lee JH (2012) Relationship between lower urinary tract symptoms/benign prostatic hyperplasia and metabolic syndrome in Korean men. World J Mens Health 30(3):183–188PubMedCentral CrossRef PubMed
  39.Wang Z, Olumi AF (2011) Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia. Differentiation 82(4–5):261–271CrossRef PubMed
  40.Marker PC, Donjacour AA, Dahiya R et al (2003) Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253(2):165–174CrossRef PubMed
  41.Kassi E, Pervanidou P, Kaltsas G et al (2011) Metabolic syndrome: definitions and controversies. BMC Med 9:48PubMedCentral CrossRef PubMed
  42.Robert G, Descazeaud A, Nicolaiew N et al (2009) Inflammation in benign prostatic hyperplasia: a 282 patients’ immunohistochemical analysis. Prostate 69(16):1774–1780PubMedCentral CrossRef PubMed
  43.Sur G, Floca E, Kudor-Szabadi L, Sur ML, Sur D et al (2014) The relevance of inflammatory markers in metabolic syndrome. Maedica (Buchar) 9(1):15–18
  44.Gacci M, Vignozzi L, Sebastianelli A et al (2013) Metabolic syndrome and lower urinary tract symptoms: the role of inflammation. Prostate Cancer Prostatic Dis 16(1):101–106CrossRef PubMed
  
• 作者单位：Chen Zou (1)
  Dandan Gong (1)
  Na Fang (1)
  Yu Fan (1)
  
  1. Institute of Molecular Biology and Translational Medicine, the Affiliated People’s Hospital, Jiangsu University, Zhenjiang, 212002, Jiangsu, People’s Republic of China
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Urology and Andrology
  Nephrology
  Oncology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-8726

文摘

Purpose To investigate the impact of metabolic syndrome (MetS) on benign prostatic hyperplasia (BPH), focusing on MetS and its relationship with prostate volume and prostate-specific antigen (PSA) in Chinese patients by performing a meta-analysis.